EICHOR
● Completed
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis
Condition: Erosive Esophagitis · Sponsor: Braintree Laboratories
About this study
The objective of the Healing Phase of the study is to evaluate the safety and efficacy of up to 8 weeks of once daily oral administration of BLI5100 versus a PPI control in healing EE. The objective of the Maintenance Phase of the study is to evaluate the safety and efficacy of 24 weeks of once daily oral administration of BLI5100 (low or high dose) versus a PPI control in the maintenance of healed EE.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (122)
| Research Site 145 | Homewood, Alabama, United States | — |
| Research Site 24 | Huntsville, Alabama, United States | — |
| Research Site 132 | Peoria, Arizona, United States | — |
| Research Site 150 | Peoria, Arizona, United States | — |
| Research Site 62 | Phoenix, Arizona, United States | — |
| Research Site 27 | Tucson, Arizona, United States | — |
| Research Site 87 | Little Rock, Arkansas, United States | — |
| Research Site 117 | North Little Rock, Arkansas, United States | — |
| Research Site 51 | Arcadia, California, United States | — |
| Research Site 66 | Bell Gardens, California, United States | — |
| Research Site 156 | Camarillo, California, United States | — |
| Research Site 19 | Canoga Park, California, United States | — |
+ 110 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05587309